{"id":47476,"date":"2022-08-19T13:02:04","date_gmt":"2022-08-19T11:02:04","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/avivagen-announces-new-dairy-customer-in-mexico\/"},"modified":"2022-08-19T13:02:04","modified_gmt":"2022-08-19T11:02:04","slug":"avivagen-announces-new-dairy-customer-in-mexico","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/avivagen-announces-new-dairy-customer-in-mexico\/","title":{"rendered":"Avivagen Announces New Dairy Customer in Mexico"},"content":{"rendered":"
\n

\n*Family-owned dairy business with established reputation for high-quality products turning to OxC-beta\u2122 to support quality of milk
\n
* Order procured through Meyenberg International, Avivagen\u2019s Mexican distribution partner<\/i>\n<\/p>\n

OTTAWA, Ontario–(BUSINESS WIRE)–Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (\u201cAvivagen\u201d), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance, is pleased to announce it has secured a promising new customer in the Mexican dairy industry. The agreement will see the customer order 220 kg\/month of OxC-beta\u2122 over a three-month period, beginning in September 2022.\n<\/p>\n

<\/a><\/p>\n

\n\u201cThis new agreement represents the continued expansion of OxC-beta\u2122 use within the dairy industry, a key growth market for Avivagen due to its size and positive economics,\u201d said Kym Anthony, Chief Executive Officer, Avivagen Inc. \u201cMexico remains an important geographic region for us. We are excited about the potential for this first dairy order in the country to lead to others in this vital industry.\u201d\n<\/p>\n

\nThe new customer, based in the Jalisco State region of Mexico, is a thirty-year old, family-owned business with a history of supplying high quality dairy products. The order follows a thorough assessment by the customer of numerous trials previously conducted in Mexico with OxC-beta\u2122, resulting in higher quality milk and yields across a range of important metrics.\n<\/p>\n

\nAbout Avivagen
\n
<\/b>Avivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance. It is a public corporation traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada. For more information, visit www.avivagen.com<\/a>. The contents of the website are expressly not incorporated by reference in this press release.\n<\/p>\n

\nAbout OxC-beta\u2122 Technology and OxC-beta\u2122 Livestock
\n
<\/b>Avivagen\u2019s OxC-beta\u2122 technology is derived from Avivagen discoveries about \u03b2-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colours. Through support of immune function the technology provides a non-antibiotic means of promoting health and growth. OxC-beta\u2122 Livestock is a proprietary product shown to be an effective and economic alternative to the antibiotics commonly added to livestock feeds. The product is currently available for sale in the United States, Philippines, Mexico, Taiwan, New Zealand, Thailand, Brazil, Australia, Vietnam and Malaysia.\n<\/p>\n

\nAvivagen\u2019s OxC-beta\u2122 Livestock product is safe, effective and could fulfill the global mandate to remove all in-feed antibiotics as growth promoters. Numerous international livestock trials with poultry and swine using OxC-beta\u2122 Livestock have proven that the product performs as well as, and, sometimes, in some aspects, better than in-feed antibiotics.\n<\/p>\n

\nForward Looking Statements
\n
<\/b>This news release includes certain forward-looking statements that are based upon the current expectations of management. Forward-looking statements involve risks and uncertainties associated with the business of Avivagen Inc. and the environment in which the business operates. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking, including those identified by the expressions \u201caim\u201d, \u201canticipate\u201d, \u201cappear\u201d, \u201cbelieve\u201d, \u201cconsider\u201d, \u201ccould\u201d, \u201cestimate\u201d, \u201cexpect\u201d, \u201cif\u201d, \u201cintend\u201d, \u201cgoal\u201d, \u201chope\u201d, \u201clikely\u201d, \u201cmay\u201d, \u201cplan\u201d, \u201cpossibly\u201d, \u201cpotentially\u201d, \u201cpursue\u201d, \u201cseem\u201d, \u201cshould\u201d, \u201cwhether\u201d, \u201cwill\u201d, \u201cwould\u201d and similar expressions.<\/i>\n<\/p>\n

\nStatements set out in this news release relating to the future growth and prospects for Avivagen, the potential for additional orders for Avivagen\u2019s products, future shipments and the possibility for OxC-beta\u2122 Livestock to replace antibiotics in livestock feeds as growth promoters are forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. For instance, Avivagen\u2019s products may not gain market acceptance or regulatory approval in new jurisdictions or for new applications and may not be widely accepted as a replacement for antibiotics as growth promoters in livestock feeds due to many factors, many of which are outside of Avivagen\u2019s control. Orders may be cancelled for many reasons outside of Avivagen\u2019s control. Readers are referred to the risk factors associated with the business of Avivagen set out in Avivagen\u2019s most recent management\u2019s discussion and analysis of financial condition available at <\/i>www.SEDAR.com<\/i><\/a>. Except as required by law, Avivagen assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements.<\/i>\n<\/p>\n

\nNeither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.<\/i>\n<\/p>\n

\nCopyright \u00a9 2022 Avivagen Inc. OxC-beta\u2122 is a trademark of Avivagen Inc.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nAvivagen Inc.
\n
Drew Basek
\n
Director of Investor Relations
\n
100 Sussex Drive, Ottawa, Ontario, Canada K1A 0R6
\n
416-540-0733
\n
d.basek@avivagen.com<\/a>\n<\/p>\n

\nKym Anthony
\n
Chief Executive Officer
\n
100 Sussex Drive, Ottawa, Ontario, Canada K1A 0R6
\n
613-949-8164
\n
www.avivagen.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

*Family-owned dairy business with established reputation for high-quality products turning to OxC-beta\u2122 to support quality of milk * Order procured through Meyenberg International, Avivagen\u2019s Mexican distribution partner OTTAWA, Ontario–(BUSINESS WIRE)–Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (\u201cAvivagen\u201d), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47476","6":"format-standard","7":"category-industry"},"yoast_head":"\nAvivagen Announces New Dairy Customer in Mexico - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/avivagen-announces-new-dairy-customer-in-mexico\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avivagen Announces New Dairy Customer in Mexico - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"*Family-owned dairy business with established reputation for high-quality products turning to OxC-beta\u2122 to support quality of milk * Order procured through Meyenberg International, Avivagen\u2019s Mexican distribution partner OTTAWA, Ontario–(BUSINESS WIRE)–Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (\u201cAvivagen\u201d), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/avivagen-announces-new-dairy-customer-in-mexico\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-19T11:02:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220819005042\/en\/1548445\/21\/Avivagen_2012_Logo_RGB%40300.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avivagen-announces-new-dairy-customer-in-mexico\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avivagen-announces-new-dairy-customer-in-mexico\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Avivagen Announces New Dairy Customer in Mexico\",\"datePublished\":\"2022-08-19T11:02:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avivagen-announces-new-dairy-customer-in-mexico\\\/\"},\"wordCount\":828,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avivagen-announces-new-dairy-customer-in-mexico\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220819005042\\\/en\\\/1548445\\\/21\\\/Avivagen_2012_Logo_RGB%40300.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avivagen-announces-new-dairy-customer-in-mexico\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avivagen-announces-new-dairy-customer-in-mexico\\\/\",\"name\":\"Avivagen Announces New Dairy Customer in Mexico - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avivagen-announces-new-dairy-customer-in-mexico\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avivagen-announces-new-dairy-customer-in-mexico\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220819005042\\\/en\\\/1548445\\\/21\\\/Avivagen_2012_Logo_RGB%40300.jpg\",\"datePublished\":\"2022-08-19T11:02:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avivagen-announces-new-dairy-customer-in-mexico\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avivagen-announces-new-dairy-customer-in-mexico\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avivagen-announces-new-dairy-customer-in-mexico\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220819005042\\\/en\\\/1548445\\\/21\\\/Avivagen_2012_Logo_RGB%40300.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220819005042\\\/en\\\/1548445\\\/21\\\/Avivagen_2012_Logo_RGB%40300.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/avivagen-announces-new-dairy-customer-in-mexico\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avivagen Announces New Dairy Customer in Mexico\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Avivagen Announces New Dairy Customer in Mexico - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/avivagen-announces-new-dairy-customer-in-mexico\/","og_locale":"en_US","og_type":"article","og_title":"Avivagen Announces New Dairy Customer in Mexico - Pharma Trend","og_description":"*Family-owned dairy business with established reputation for high-quality products turning to OxC-beta\u2122 to support quality of milk * Order procured through Meyenberg International, Avivagen\u2019s Mexican distribution partner OTTAWA, Ontario–(BUSINESS WIRE)–Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (\u201cAvivagen\u201d), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/avivagen-announces-new-dairy-customer-in-mexico\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-19T11:02:04+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220819005042\/en\/1548445\/21\/Avivagen_2012_Logo_RGB%40300.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/avivagen-announces-new-dairy-customer-in-mexico\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/avivagen-announces-new-dairy-customer-in-mexico\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Avivagen Announces New Dairy Customer in Mexico","datePublished":"2022-08-19T11:02:04+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/avivagen-announces-new-dairy-customer-in-mexico\/"},"wordCount":828,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/avivagen-announces-new-dairy-customer-in-mexico\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220819005042\/en\/1548445\/21\/Avivagen_2012_Logo_RGB%40300.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/avivagen-announces-new-dairy-customer-in-mexico\/","url":"https:\/\/pharma-trend.com\/en\/avivagen-announces-new-dairy-customer-in-mexico\/","name":"Avivagen Announces New Dairy Customer in Mexico - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/avivagen-announces-new-dairy-customer-in-mexico\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/avivagen-announces-new-dairy-customer-in-mexico\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220819005042\/en\/1548445\/21\/Avivagen_2012_Logo_RGB%40300.jpg","datePublished":"2022-08-19T11:02:04+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/avivagen-announces-new-dairy-customer-in-mexico\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/avivagen-announces-new-dairy-customer-in-mexico\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/avivagen-announces-new-dairy-customer-in-mexico\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220819005042\/en\/1548445\/21\/Avivagen_2012_Logo_RGB%40300.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220819005042\/en\/1548445\/21\/Avivagen_2012_Logo_RGB%40300.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/avivagen-announces-new-dairy-customer-in-mexico\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Avivagen Announces New Dairy Customer in Mexico"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47476","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47476"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47476\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47476"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47476"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47476"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}